XBIO

Xenetic Biosciences, Inc. XBIO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XBIO NBY INM GOVX PHIO NAOV VTVT SNOA IMMP WORX
6M 137.94 % 121.74 % -23.54 % -48.17 % 25.00 % -90.86 % 14.38 % 78.60 % 37.67 % -62.93 %
YTD 35.13 % 88.00 % -56.35 % -78.68 % 14.47 % -90.92 % 58.22 % 52.61 % -9.05 % -83.93 %
1Y 47.51 % 91.06 % -49.40 % -73.70 % -19.14 % -90.92 % 62.16 % 32.79 % -4.74 % -74.95 %
3Y 1.34 % -99.04 % -98.15 % -96.31 % -96.47 % -99.36 % -36.48 % -89.45 % 8.06 % -97.10 %
5Y -39.93 % -99.87 % -99.88 % -98.80 % -99.08 % -99.60 % -69.15 % -97.62 % -64.92 % -98.72 %
10Y -99.11 % -99.99 % -99.90 % -98.80 % -100.00 % -99.93 % -92.05 % -99.61 % -85.19 % -99.98 %
From the beginning -99.11 % -100.00 % -99.95 % -98.80 % -99.31 % -99.92 % -95.07 % -99.99 % -98.50 % -99.98 %

Dividend

NovaBay Pharmaceuticals, Inc.